Spyre Therapeutics Advances SPY772 into Phase 2 for Hidradenitis Suppurativa
Waltham, Mass., August 10, 2026 Spyre Therapeutics, Inc. announced the launch of its SPY772 combination program and initiation of...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
Waltham, Mass., August 10, 2026 Spyre Therapeutics, Inc. announced the launch of its SPY772 combination program and initiation of...
Bagsværd, Denmark, August 10, 2026 Novo Nordisk and Amazon Web Services (AWS) announced a strategic partnership aimed at accelerating...
Aurora, Colorado, August 3, 2026 A University of Colorado Anschutz Medical Campus-led multicenter clinical trial has demonstrated that an...
SILVER SPRING, Md., July 29, 2026 The U.S. Food and Drug Administration (FDA) has licensed Ezplaz Freeze Dried Plasma...
NANJING, China, August 3, 2026 Leads Biolabs announced that the Center for Drug Evaluation (CDE) of China’s National Medical...
CULVER CITY, Calif., July 28, 2026 Avenda Health announced that its FDA-cleared Unfold AI platform is now being used...
ORLANDO, Fla., July 30, 2026 Andor Health announced that its AI-native clinical services operating platform, ThinkAndor®, has reached General...
MENLO PARK, Calif., July 31, 2026 Hippocratic AI has launched a new suite of Rapid Response Climate Agents, enabling...
WOODBRIDGE, N.J., July 29, 2026 Knack RCM has highlighted its specialty-intelligent, AI-native anesthesia revenue cycle management platform, combining more...
TAMPA, Fla., July 16, 2026 Inspirata AI has officially unveiled its new corporate identity, transitioning from Inspirata to Inspirata...
